Skip to main content
. 2004 Dec 20;563(Pt 1):193–201. doi: 10.1113/jphysiol.2004.078642

Table 2.

125I-labelled angiotensin II (Ang II) binding characteristics of glomeruli from control and low-protein (LP) rats

Control LP
Bmax
125I-Ang II 291.6 ± 27.4 445.7 ± 27.4
125I-Ang II and losartan 44.4 ± 5.89 26.3 ± 3.85*
125I-Ang II and PD123319 217.4 ± 16.3 370.5 ± 19.7
KD
125I-Ang II 2.87 ± 0.85 0.84 ± 0.20
125I-Ang II and losartan 2.45 ± 1.06 0.74 ± 0.45
125I-Ang II and PD123319 2.19 ± 0.55 0.73 ± 0.16*

The binding constant (Bmax, expressed in femtomoles per milligram glomerular protein) and binding affinity (KD, expressed in picomoles of 125I-Ang II) are shown for 125I-Ang II alone (10−10–10−7m, control n = 9 from 6 litters, LP n = 7 from 6 litters), 125I-Ang II plus the AT1 receptor antagonist losartan (10−4m, control n = 7 from 5 litters, LP n = 7 from 5 litters) and 125I-Ang II plus the AT2 receptor antagonist PD123319 (10−4m, control n = 7 from 5 litters, LP n = 7 from 5 litters). Data are presented as means ±s.e.m. Statistical comparisons were by one-way ANOVA and Duncan's test. Differences between control and LP glomeruli treated in the same manner are shown

*

(P < 0.05,

P < 0.01,

P < 0.001); for comparisons between different treatments see the results text.